Published in Eur J Heart Fail on June 01, 2011
Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol (2009) 2.96
Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J (2003) 2.56
Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol (2005) 2.10
Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study. Int J Cardiol (2011) 2.06
Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care (2011) 1.91
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun (2012) 1.88
Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol (2004) 1.83
Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease. Eur Heart J (2004) 1.80
Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ Res (2008) 1.76
Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation (2003) 1.63
Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol (2010) 1.61
Dose-response relationship of autonomic nervous system responses to individualized training impulse in marathon runners. Am J Physiol Heart Circ Physiol (2009) 1.59
CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16. Circulation (2005) 1.44
Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women. J Cardiovasc Med (Hagerstown) (2009) 1.44
Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood (2002) 1.44
Metabolic agents in the management of diabetic coronary patients: a new era. Int J Cardiol (2008) 1.40
High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA). J Gerontol A Biol Sci Med Sci (2013) 1.32
A pilot study of nurse-led, home-based telecardiology for patients with chronic heart failure. J Telemed Telecare (2004) 1.20
Oxidative stress induces p53-mediated apoptosis in glia: p53 transcription-independent way to die. J Neurosci Res (2004) 1.16
Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation. Ann Thorac Surg (2004) 1.15
Immunoregulation through extracellular nucleotides. Blood (2012) 1.14
Cellular models for understanding adipogenesis, adipose dysfunction, and obesity. J Cell Biochem (2010) 1.09
Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy. Mol Vis (2011) 1.09
Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood (2002) 1.08
Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease. Basic Res Cardiol (2013) 1.05
Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study. Cardiovasc Diabetol (2003) 1.05
Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome. Endocrinology (2010) 1.05
Antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis. J Immunol (2006) 1.03
Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism. J Am Heart Assoc (2013) 1.02
Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial). Int J Cardiol (2011) 1.00
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism. Mol Cell Endocrinol (2011) 0.98
Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response. Circulation (2003) 0.98
Cyclic adenosine 5'-monophosphate and calcium induce CD152 (CTLA-4) up-regulation in resting CD4+ T lymphocytes. J Immunol (2002) 0.98
Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol (2007) 0.98
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome. Cardiovasc Diabetol (2005) 0.98
Expression and function of histamine receptors in human monocyte-derived dendritic cells. J Allergy Clin Immunol (2002) 0.95
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther (2011) 0.94
Metabolic therapy for patients with diabetes mellitus and coronary artery disease. Am J Cardiol (2006) 0.94
Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival. Hepatogastroenterology (2003) 0.92
Mineralocorticoid receptors in the metabolic syndrome. Trends Endocrinol Metab (2009) 0.92
Hormone replacement therapy and cardioprotection: the end of the tale? Ann N Y Acad Sci (2003) 0.92
Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure. Am J Physiol Cell Physiol (2003) 0.92
Cardiac metabolism in myocardial ischemia. Curr Pharm Des (2008) 0.91
Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism. J Clin Endocrinol Metab (2003) 0.90
Tai chi enhances the effects of endurance training in the rehabilitation of elderly patients with chronic heart failure. Rehabil Res Pract (2010) 0.90
The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes. FEBS J (2013) 0.90
The functional c.-2G>C variant of the mineralocorticoid receptor modulates blood pressure, renin, and aldosterone levels. Hypertension (2010) 0.90
Assessment of prehospital chest pain using telecardiology. J Telemed Telecare (2002) 0.89
Hypogonadism in a patient with two novel mutations of the luteinizing hormone β-subunit gene expressed in a compound heterozygous form. J Clin Endocrinol Metab (2012) 0.89
Androgens and adipose tissue in males: a complex and reciprocal interplay. Int J Endocrinol (2011) 0.89
Activation of human eosinophils via P2 receptors: novel findings and future perspectives. J Leukoc Biol (2005) 0.88
Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients. J Card Fail (2011) 0.88
Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study. Int J Cardiol (2012) 0.88
CTLA-4 engagement inhibits Th2 but not Th1 cell polarisation. Clin Dev Immunol (2003) 0.87
ATP secreted by endothelial cells blocks CX₃CL 1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y₁₁ receptor activation. Blood (2010) 0.87
Observational study on Takotsubo-like cardiomyopathy: clinical features, diagnosis, prognosis and follow-up. BMJ Open (2012) 0.87
Matched dose interval and continuous exercise training induce similar cardiorespiratory and metabolic adaptations in patients with heart failure. Int J Cardiol (2012) 0.87
Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism? Trends Endocrinol Metab (2011) 0.87
Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system? Ann N Y Acad Sci (2006) 0.86
Incidence of atrial fibrillation in an Italian population followed by their GPs through a telecardiology service. Int J Cardiol (2005) 0.86
Sex differences in drug effects: interaction with sex hormones in adult life. Handb Exp Pharmacol (2012) 0.86
Altered autonomic cardiac regulation in individuals with Down syndrome. Am J Physiol Heart Circ Physiol (2005) 0.85
Androgen receptor expression during C2C12 skeletal muscle cell line differentiation. Mol Cell Endocrinol (2008) 0.85
Sildenafil reduces insulin-resistance in human endothelial cells. PLoS One (2011) 0.85
Plasma levels of inflammatory C-reactive protein and interleukin-6 predict outcome in elderly patients with stroke. J Am Geriatr Soc (2004) 0.84
ACTH and alpha-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathway. Mol Cell Endocrinol (2003) 0.83
Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease. Int J Cardiol (2006) 0.83
Effect of High-Intensity interval training versus moderate continuous training on 24-h blood pressure profile and insulin resistance in patients with chronic heart failure. Intern Emerg Med (2013) 0.83
Lipid profiles and endothelial function with low-dose hormone replacement therapy in postmenopausal women at risk for coronary artery disease: a randomized trial. Int J Cardiol (2003) 0.82
Endothelial effects of drugs designed to treat erectile dysfunction. Curr Pharm Des (2008) 0.82
Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy. Adv Ther (2009) 0.82
Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors. PLoS One (2010) 0.82
Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity. J Steroid Biochem Mol Biol (2013) 0.82
Dose-response relationship of baroreflex sensitivity and heart rate variability to individually-tailored exercise training in patients with heart failure. Int J Cardiol (2011) 0.82
Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease. Int J Cardiol (2009) 0.82